Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Precision medicine in cholangiocarcinoma.
Pellino A, Loupakis F, Cadamuro M, Dadduzio V, Fassan M, Guido M, Cillo U, Indraccolo S, Fabris L. Pellino A, et al. Among authors: guido m. Transl Gastroenterol Hepatol. 2018 Jul 12;3:40. doi: 10.21037/tgh.2018.07.02. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30148225 Free PMC article. Review.
Necroptosis in Cholangiocarcinoma.
Sarcognato S, Jong IEM, Fabris L, Cadamuro M, Guido M. Sarcognato S, et al. Among authors: guido m. Cells. 2020 Apr 15;9(4):982. doi: 10.3390/cells9040982. Cells. 2020. PMID: 32326539 Free PMC article. Review.
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.
Cadamuro M, Lasagni A, Lamarca A, Fouassier L, Guido M, Sarcognato S, Gringeri E, Cillo U, Strazzabosco M, Marin JJ, Banales JM, Fabris L. Cadamuro M, et al. Among authors: guido m. Expert Opin Investig Drugs. 2021 Apr;30(4):377-388. doi: 10.1080/13543784.2021.1880564. Epub 2021 Feb 23. Expert Opin Investig Drugs. 2021. PMID: 33622120 Free PMC article. Review.
Cholangiocarcinoma.
Sarcognato S, Sacchi D, Fassan M, Fabris L, Cadamuro M, Zanus G, Cataldo I, Capelli P, Baciorri F, Cacciatore M, Guido M. Sarcognato S, et al. Among authors: guido m. Pathologica. 2021 Jun;113(3):158-169. doi: 10.32074/1591-951X-252. Pathologica. 2021. PMID: 34294934 Free PMC article. Review.
Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma.
Cadamuro M, Romanzi A, Guido M, Sarcognato S, Cillo U, Gringeri E, Zanus G, Strazzabosco M, Simioni P, Villa E, Fabris L. Cadamuro M, et al. Among authors: guido m. J Pers Med. 2022 Jun 30;12(7):1086. doi: 10.3390/jpm12071086. J Pers Med. 2022. PMID: 35887583 Free PMC article. Review.
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study.
Rizzato M, Brignola S, Munari G, Gatti M, Dadduzio V, Borga C, Bergamo F, Pellino A, Angerilli V, Mescoli C, Guido M, Rearden J, Gringeri E, Cillo U, Dei Tos AP, Zagonel V, Loupakis F, Lonardi S, Fassan M. Rizzato M, et al. Among authors: guido m. Eur J Cancer. 2022 May;166:165-175. doi: 10.1016/j.ejca.2022.02.013. Epub 2022 Mar 15. Eur J Cancer. 2022. PMID: 35303508
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas.
Pellino A, Brignola S, Riello E, Niero M, Murgioni S, Guido M, Nappo F, Businello G, Sbaraglia M, Bergamo F, Spolverato G, Pucciarelli S, Merigliano S, Pilati P, Cavallin F, Realdon S, Farinati F, Dei Tos AP, Zagonel V, Lonardi S, Loupakis F, Fassan M. Pellino A, et al. Among authors: guido m. J Pers Med. 2021 Oct 26;11(11):1095. doi: 10.3390/jpm11111095. J Pers Med. 2021. PMID: 34834447 Free PMC article.
607 results